In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...

Recent breakthroughs by The Institute of Cancer Research in London and the University of Virginia in the U.S. could cut drug ...

TriSalus Life Sciences expects 50% sales growth and EBITDA positivity in 2025. See why TLSI stock could benefit, with key ...

Based on Intelligencia AI’s comprehensive, proprietary database of over 20,000 industry-sponsored, interventional oncology clinical programs (around 12,400 clinical trials), recent insights highlight ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement ...

Two AI healthcare stocks -- Recursion Pharmaceuticals ( RXRX -2.76%) and Teladoc Health ( TDOC -5.20%) -- have lagged the ...

The Los Angeles/Orange County market was a high point, with rising asking rent compared to previous years and vacancy rates ...

Lo, the former head of therapeutic development at the National Center for Advancing ... 10 years to create some new drug from ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

Longfellow Real Estate Partners and PGIM have revised plans for an 84-acre life sciences development in Redwood City, now ...

Joseph Coates, left, owes his life to an A.I. model developed by ... said Christine Colvis, who heads drug development partnership programs at NCATS. That’s what makes drug repurposing such ...